Clinical Trial Update: Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial reports on the optimal duration of dual antiplatelet therapy after implantation of the Endeavor zotarolimus-eluting stent in real-world Japan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Endeavor zotarolimus-eluting stent (zotarolimus)

Snippet

Sponsor: Associations for Establishment of Evidence in Interventions | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED